Budesonide reduces superoxide and peroxynitrite anion chemiluminescence during human neutrophil bursts

Pharmacology

Volumn 75, Issue 4, 2005, Pages 179-186

  Braga, Pier Carlo ^a,d   Dal Sasso, Monica ^a   Culici, Maria ^a   Bianchi, Tiziana ^b   Guffanti, Enrico Eugenio ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b AVIS   (Italy)

^c INRCA   (Italy)

^d Department of Pharmacology ^*  (Italy)

Author keywords

Budesonide; Luminol amplified chemiluminescence; Nitric oxide; Peroxynitrite; Polymorphonuclear neutrophils; Superoxide anion

Indexed keywords

ANION; ARGININE; BUDESONIDE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ANTAGONIST; LUMINOL; MIFEPRISTONE; NITRIC OXIDE; PEROXYNITRITE; PHORBOL 13 ACETATE 12 MYRISTATE; SUPEROXIDE;

ANTIOXIDANT ACTIVITY; ARTICLE; ASTHMA; CHEMOLUMINESCENCE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG TARGETING; HUMAN; HUMAN CELL; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; RESPIRATORY BURST;

ANTI-INFLAMMATORY AGENTS; ARGININE; BUDESONIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LUMINESCENCE; LUMINOL; MIFEPRISTONE; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; NITRIC OXIDE; NITRIC OXIDE DONORS; PEROXYNITROUS ACID; RECEPTORS, GLUCOCORTICOID; RESPIRATORY BURST; SUPEROXIDES;

EID: 31544458708     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088623     Document Type: Article

References (69)

1. Martin LD, Rochelle LG, Fischer BM, Krunkosky TM, Adler KB: Airway epithelium as an effector of inflammation: molecular regulation of secondary mediators. Eur Respir J 1997;10:2139-2146.
2. Cromwell O, Hamid Q, Conigan C, Barkans J, Ueng Q, Collins P: Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1β and tumor necrosis factor-α. Immunology 1992;7:330-337.
3. Adler K, Fischer B, Wright D, Cohn L, Becker S: Interaction between respiratory epithelial cell and cytokines: relationships to lung inflammation. Ann NY Acad Sci 1994;725:128-145.
4. Cohn LA, Fischer BM, Krunkosky TM, Wright DT, Adler KB: Airway epithelial cells in asthma; in Lay AB (ed): Allergy and Allergic Diseases. Oxford, Blackwell Scientific, 1997, pp 263-283.
5. Christman JW, Sadikot RT, Blackwell TS: The role of nuclear factor-κB in pulmonary diseases. Chest 2000;117:1482-1487.
6. Levine SJ: Bronchial epithelial cell-cytokine interactions in airway inflammation. J Investig Med 1995;43:241-249.
7. Ichinose M, Sugiura H, Yamagata S, Koarai A, Shirato K: Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med 2000;162:701-706.
8. Kanazawa H, Shiraishi S, Hirata K, Yoshikawa J: Imbalance between levels of nitrogen oxides and peroxynitrite inhibitory activity in chronic obstructive pulmonary disease. Thorax 2003;58:106-109.
9. Lehrer RI, Ganz T, Selsted ME, Babior BM, Curnutte JT: Neutrophils and host defense. Ann Intern Med 1988;19:127-142.
10. Venge P, Rak S, Steinholtz L, Hakansson L, Lindblad G: Neutrophil function in chronic bronchitis. Eur Respir J 1991;4:536-543.
11. Müns G, Rubinstein I, Singer P: Phagocytosis and oxidative burst of granulocytes in the upper respiratory tract in chronic and acute inflammation. J Otolaryngol 1995;24:105-110.
12. 4. FEBS Lett 1989;244:357-360.
13. Stolarek R, Kula P, Kurmanowska Z, Nowak D: Effect of various agonists on nitric oxide generation by human polymorphonuclear leukocytes. Int J Clin Lab Res 1998;28:104-109.
14. Radi R, Cosgrove TP, Beckman JS, Freeman BA: Peroxynitrite-induced luminol chemiluminescence. Biochem J 1993;290:51-57.
15. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-1624.
16. Hogg N, Darley-Usmar VM, Wilson MT, Moncada S: Production of hydroxyl radicals from simultaneous generation of superoxide and nitric oxide. Biochem J 1992;28:419-424.
17. Vachier I, Chanez P, Le Doucen C, Damon M, Descomps B, Godard P: Enhancement of reactive oxygen species formation in stable and unstable asthmatic patients. Eur Respir J 1994;7:1585-1592.
18. Kato M, Morikawa A, Kimura H, Shimizu T, Nakano M, Kuroume T: Effects of antiasthma drugs on superoxide anion generation from human polymorphonuclear leukocytes or hypoxanthine-xanthine oxidase system. Int Arch Allergy Appl Immunol 1991;96:128-133.
19. Neijens HJ, Kaatgeep HC, Degenhart HJ, Kerrebijn KF: Response of neutrophilic granulocytes in vitro of asthmatic and healthy subjects and the degree of inhibition by several drugs. Agents Action 1989;26:108-110.
20. McCall TB, Palmer RMJ, Moncada S: Induction of nitric oxide synthase in rat peritoneal neutrophils and its inhibition by dexamethasone. Eur J Immunol 1991;21:2523-2527.
21. Kanazawa H, Shiraishi S, Hirata K, Yoshikawa J: Decreased peroxynitrite inhibitory activity in induced sputum in patients with bronchial asthma. Thorax 2002;57:509-512.
22. Saleh D, Ernst P, Lim S, Barnes PJ, Giaid A: Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J 1998;12:929-937.
23. Briheim G, Stendhal O, Dahlgren C: Intra- and extracellular events in luminol-dependant chemiluminescence of polymorphonuclear leukocytes. Infect Immun 1984;45:1-8.
24. Robinson P, Wakefield D, Breit SN, Easter JF, Penny R: Chemiluminescence response to pathogenic organisms: normal human polymorphonuclear leukocytes. Infect Immun 1984;43:744-752.
25. Allen RC: Phagocytic oxygenation activities and chemiluminescence: a kinetic approach to analysis. Methods Enzymol 1986;133:449-493.
26. Merenyi G, Lind J, Eriksen TE: Luminol chemiluminescence: chemistry, excitation, emitter. J Biolumin Chemilumin 1990;5:53-56.
27. Zhao BL, Wang JC, Hou JW, Xin WJ: Studies on nitric oxide free radicals generated from polymorphonuclear leukocytes stimulated by phorbol myristate acetate. Cell Biol Int 1996;20:343-350.
28. Badwey JA, Kaendsky ML: Active oxygen species and the functions of phagocytic leukocytes. Annu Rev Biochem 1980;49:695-726.
29. Carreras MC, Pargament GA, Cotz SD, Poderoso JJ, Boveris A: Kinetics of nitric oxide and hydrogen peroxide production and formation of peroxynitrite during the respiratory burst of human neutrophils. FEBS Lett 1994;341:65-68.
30. Forslund T, Sundqvist T: Nitric oxide regulates the chemiluminescence from stimulated human neutrophils. APMIS 1995;103:813-817.
31. Ischiropoulos H, Zhu L, Beckman JS: Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys 1992;298:446-451.
32. Wang JF, Komarov P, Sies H, De Groot H: Contribution of nitric oxide synthase to luminol-dependent chemiluminescence generated by phorbol-ester activated Kupffer cells. Biochem J 1991;279:311-314.
33. Briheim G, Dahlgren C: Influence of antibiotics on formylmethionyl- leucyl-phenylalanine-induced leukocyte chemiluminescence. Antimicrob Agents Chemother 1987;31:763-769.
34. Agarwai MK: The antiglucocorticoid action of mifepristone. Pharmacol Ther 1996;70:183-213.
35. Van Dyke K, McConnell P, Marquardt L: Green tea extract and its polyphenols markedly inhibit luminol-dependent chemiluminescence activated by peroxynitrite or SIN-1. Luminescence 2000;15:37-43.
36. Radi R, Beckman JS, Bush KM: Peroxynitrite oxidation of sulphydryls. The cytotoxic potentials of superoxide and nitric oxide. J Biol Chem 1991;266:4244-4250.
37. Rahman I: Oxidative stress, transcription factors and chromatin remodelling in lung inflammation. Biochem Pharmacol 2002;64:935-942.
38. 3 phosphorylation is coupled to poly-(ADP-ribosylation) during reactive oxygen species-induced cell death in renal proximal tubular epithelial cells. Mol Pharmacol 2001;60:394-402.
39. Bohm L, Schneeweiss FA, Sharan RN, Feinendegen LE: Influence of histone acetylation on the modification of cytoplasmic and nuclear proteins by ADP-ribosylation in response to free radicals. Biochim Biophys Acta 1997;1334:149-154.
40. Rahman I, MacNee W: Role of transcription factors in inflammatory lung diseases. Thorax 1998;55:601-612.
41. 2. J Biol Chem 1996;271:4138-4142.
42. Chung KE: Role of inflammation in the hyperreactivity of the airways in asthma. Thorax 1986;41:675-680.
43. Babior BM: Activation of the respiratory burst oxidase. Environ Health Perspect 1994;102(suppl 10):53-56.
44. Sadeghi-Hashjin G, Folkerts G, Henricks PAJ, Verheyen AKCP, Linde HJ, Ark I, Coene A, Nijkamp FP: Peroxynitrite induces airway hyperresponsiveness in guinea pigs in vitro and in vivo. Am J Respir Crit Care Med 1996;153:1697-1701.
45. Haddad IY, Ischiropoulos H, Holm BA, Beckman JS, Baker JR, Matalon S: Mechanism of peroxynitrite induced injury to pulmonary surfactants. Am J Physiol 1993;265:L555-L564.
46. Matalon S, Hu P, Ischiropoulos H, Beckman JS: Peroxynitrite inhibition of oxygen consumption and ions transport in alveolar type II pneumocytes. Chest 1994;105:74S.
47. Massaro AF, Mehta S, Lilly CM, Kobzik L, Reilly JJ, Drazen JM: Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects. Am J Respir Crit Care Med 1996;153:1510-1514.
48. Jarjour NN, Calhoun WJ: Enhanced production of oxygen radicals in asthma. J Lab Clin Med 1994;123:131-136.
49. Calhoun WJ, Reed HE, Moest DR, Stevens CA: Enhanced superoxide production by alveolar macrophages and airspace cells, airway inflammation and alveolar macrophage density changes after segmental antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis 1992;145:317-325.
50. Barnes PJ: Pathophysiology of asthma. Br J Clin Pharmacol 1996;42:3-10.
51. Teramoto S, Shu CY, Ouchi Y, Fukuchi Y: Increased spontaneous production and generation of superoxide anion by blood neutrophils in patients with asthma. J Asthma 1996;33:149-155.
52. Kharitonov SA, Yates DH, Barnes PJ: Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996;153:454-457.
53. Yates DH, Kharatinov SA, Robbins RA, Thomas PS, Barnes PJ: Effect of nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. Am J Respir Crit Care Med 1995;152:892-896.
54. Li Y, Ito N, Suzuki T, Stechschulte DJ, Dileepan KN: Dexamethasone inhibits nitric oxide-mediated cytotoxicity via effects on both macrophages and target cells. Immunopharmacology 1995;30:177-186.
55. Pelaia G, Vatrella A, Cuda G, Maselli R, Marsico SA: Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases. Life Sci 2003;72:1549-1561.
56. Gundersen Y, Vaagenes P, Myhre O, Andersen JM, Pharo A, Haugen AH, Valoe E, Opstad PK: Hydrocortisone and the mitogen-activated protein kinase inhibitor UO126 acutely suppress reactive oxygen species generation from circulating granulocytes after gunshot injuries in the pig. Crit Care Med 2003;31:166-170.
57. Falkenstein E, Tillmann HC, Christ M, Feuring M, Wehling M: Multiple actions of steroids hormones: a focus on rapid nongenomic effects. Pharmacol Rev 2000;52:513-556.
58. Barnes PJ: Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci 1998;94:557-572.
59. Umeki S, Soejima R. Hydrocortisone inhibits the respiratory burst oxidative from neutrophils in a whole-cell and cell-free system. Biochim Biophys Acta 1990;1052:211-215.
60. Dandona P, Suri M, Hamouda W, Aljada A, Kumbkami Y, Thusu K: Hydrocortisone-induced inhibition of reactive oxygen species by polymorphonuclear neutrophils. Crit Care Med 1999;27:2442-2444.
61. Li YH, Yan ZQ, Jensen JS, Tullus K, Branner A: Activation of nuclear factor-κB and induction of inducible nitric oxide synthase by Urea-plasma urealyticum in macrophages. Infect Immun 2000;68:7087-7093.
62. Beckman JST, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-1624.
63. Grisham MB, Jourd'Heuil D, Wink DA: Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites implications in inflammation. Am J Physiol 1999;276:G315-G321.
64. Di Rosa M, Radomski M, Carnuccio R, Moncada S: Glucocorticoids inhibit the induction of nitric oxide synthase in macrophage. Biochem Biophys Res Commun 1990;172:1246-1252.
65. Xie QW, Kashiwabara Y, Nathan C: Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem 1994;269:4705-4708.
66. Spoelstra FM, Postma DS, Hovenga H, Noordhoek JA, Kauffman HF: Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts. Thorax 2002;57:237-241.
67. Borski RJ: Nongenomic membrane actions of glucocorticoids in vertebrates. Trends Endocrinol Metab 2000;11:427-436.
68. Cato ACB, Nestl A, Mink S: Rapid actions of steroid receptors in cellular signaling pathways. Sci STKE, RE9.
69. Lösel R, Wehling M: Nongenomic actions of steroid hormones. Nature 2003;4:46-56.